Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2010
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261702 Thiophene derivatives as agonists of s1p1/edg1
10/14/2010US20100261698 Organic compounds
10/14/2010US20100261655 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100260817 Polyamine Derivatives
10/14/2010US20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF
10/14/2010US20100260775 Treatment Of Interstitial Cystitis
10/14/2010US20100260749 Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260703 Injectable biodegradable polymer compositions for soft tissue repair and augmentation
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010CA2757327A1 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
10/13/2010EP2239581A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation
10/13/2010EP2239253A1 Novel phenylpyrrole derivative
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238116A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238115A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238114A1 Novel imidazolinylmethyl aryl sulfonamides
10/13/2010EP2238113A1 N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence
10/13/2010EP1553972B1 Chorionic gonadotropin for use in the treatment of chronic pelvic pain syndrome
10/13/2010EP1381631B1 Human anti timp-1 antibodies
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010EP1255553B1 Use of trilostane or keto-trilostane in combination with an antioestrogen in the treatment of a hormone-dependent condition.
10/13/2010CN1909916B Effervescent composition including cranberry extract
10/13/2010CN1795845B Slow release microsphere preparation of derivative of 3,3 - diphenyl propylamine as receptor antagon of toadstool alkali in use for injection
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861319A Benzazepinone compound
10/13/2010CN101857573A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/13/2010CN101856490A Method for preparing Sini decoction granules from unprocessed radix aconiti lateralis
10/13/2010CN101856471A Chinese medicinal composition for tonifying kidney and strengthening body
10/13/2010CN101856457A Medicine with kidney tonifying, essence replenishing and yang invigorating functions and preparation method thereof
10/13/2010CN101856450A Chinese medicinal composition for treating diabetic nephropathy
10/13/2010CN101856449A Chinese medicinal composition for clearing heat and promoting diuresis, activating blood and treating stranguria, preparation method and quality detection method
10/13/2010CN101856444A Optimization of film coating technology of shenshuanning tablet
10/13/2010CN101856439A Chestnutsdispe capsule and preparation method thereof
10/13/2010CN101856433A Application of Puer tea in preparing dugs for preventing oxidative stress caused by immunosenescence or other relevant disease thereof
10/13/2010CN101856418A Pharmaceutical preparation for preventing nephritis and preparation method thereof
10/13/2010CN101856404A Chinese medicament for treating uremia
10/13/2010CN101856395A Method for preparing cistanche deserticola crude drug for decoction
10/13/2010CN101856393A Application of compound Yiganling composition in aspect of auxiliary treatment of chemotherapy of tumors
10/13/2010CN101856388A Medicament for treating urinary calculus and benign prostatic hyperplasia
10/13/2010CN101856377A Compound preparation for treating nephrotic syndromes
10/13/2010CN101856346A Medical application of coumaroyl spermidine type compounds or plant extracts thereof
10/13/2010CN101856338A Potassium citrate slow-releasing pill
10/13/2010CN101856333A Freeze-dried powder injection of cefamandole nafate and preparation method thereof
10/13/2010CN101856324A Method for preparing phloroglucinol injection
10/13/2010CN101856116A Application of coumaroyl spermidine type compounds or plant extracts thereof
10/13/2010CN101496577B Special diet and foodstuffs formula containing small peptide for patient with kidney disease
10/13/2010CN101284065B Chinese medicinal composition for treating the prostatitis and preparation method thereof
10/13/2010CN101204493B Peroral Chinese traditional medicine composition for chronic nephritis
10/13/2010CN101099567B Kidney-tonifying and hair-blackening food
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2457050C Prophylactic and therapeutic use of hydroxysteroids
10/12/2010CA2455526C Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/07/2010WO2010113942A1 Indolizine derivative and use thereof for medical purposes
10/07/2010WO2010113841A1 Orally disintegrating coated tablet
10/07/2010WO2010113840A1 Solid pharmaceutical composition containing amorphous body of solifenacin
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010078833A8 Modified sodium-montmorillonite, preparing method and uses thereof
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100256240 Prostacyclin derivatives
10/07/2010US20100256231 Novel derivatives of 3,3-diphenylpropylamines
10/07/2010US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256146 Trisubstituted piperidines
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256140 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256111 Therapeutic agents useful for treating pain
10/07/2010US20100255093 Sustained release oral dosage forms of an r-baclofen prodrug
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100254997 ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254970 Ngal for reduction and amelioration of ischemic and nephrotoxic injuries
10/07/2010US20100254953 Cell growth method and pharmaceutical preparation for tissue repair and regeneration
10/07/2010DE102009015002A1 Topical application form, useful for treating e.g. pruritus, burnt skin, dry skin, comprises a carrier material, which is applied with a hydrocolloid matrix and the matrix comprises two hydrocolloids or hydro-gels and one excipient
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756877A1 Orally disintegrating coated tablet
10/07/2010CA2755132A1 Indolizine derivative and use thereof for medical purposes
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2235003A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
10/06/2010EP2234989A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
10/06/2010EP2234972A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
10/06/2010EP2234482A1 Sulfate salt prophylaxis and therapies
10/06/2010EP1513543B1 Fas peptide mimetics and uses thereof
10/06/2010CN1681508B Novel inhibitors of kinases
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 562